Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Novak's Stock Ratings
Raymond James Analyst
David Novak is an analyst at Raymond James. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2025
Overall Average Return
-1.30%
Smart Score
Overall Average Return Percentile
34th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/06/2024 | KHTRF | Buy Now | Knight Therapeutics | — | — | David Novak43% | $7 → $7.5 | Maintains | Outperform | Get Alert |
| 02/22/2022 | MDP | Buy Now | Medexus Pharma | — | — | David Novak43% | → $5.5 | Initiates | → Outperform | Get Alert |
| 12/10/2021 | ZYME | Buy Now | Zymeworks | $11.71 | 531.94% | David Novak43% | → $74 | Downgrade | Strong Buy → Outperform | Get Alert |
| 11/09/2021 | ZIOP | Buy Now | ZIOPHARM Oncology | — | — | David Novak43% | $3 → $2 | Maintains | Market Perform | Get Alert |
| 08/10/2021 | ZIOP | Buy Now | ZIOPHARM Oncology | — | — | David Novak43% | → $3 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/07/2021 | ZIOP | Buy Now | ZIOPHARM Oncology | — | — | David Novak43% | $5.5 → $4 | Maintains | Outperform | Get Alert |
| 03/02/2021 | LPTX | Buy Now | Leap Therapeutics | $0.39 | 797.44% | David Novak43% | $2.5 → $3.5 | Maintains | Outperform | Get Alert |
| 02/04/2021 | CBIO | Buy Now | Catalyst Biosciences | — | — | David Novak43% | $20 → $18 | Maintains | Outperform | Get Alert |
| 01/19/2021 | ZYME | Buy Now | Zymeworks | $11.71 | 531.94% | David Novak43% | $60 → $74 | Maintains | Strong Buy | Get Alert |
| 03/03/2020 | ZIOP | Buy Now | ZIOPHARM Oncology | — | — | David Novak43% | $6.5 → $5.5 | Maintains | Outperform | Get Alert |
| 01/08/2020 | LPTX | Buy Now | Leap Therapeutics | $0.39 | 541.03% | David Novak43% | → $2.5 | Upgrade | Market Perform → Outperform | Get Alert |
| 11/25/2019 | ZYME | Buy Now | Zymeworks | $11.71 | 412.38% | David Novak43% | $40 → $60 | Maintains | Strong Buy | Get Alert |
| 09/30/2019 | ZYME | Buy Now | Zymeworks | $11.71 | 241.59% | David Novak43% | $36 → $40 | Upgrade | Outperform → Strong Buy | Get Alert |
| 08/23/2019 | ZIOP | Buy Now | ZIOPHARM Oncology | — | — | David Novak43% | → $6.5 | Reinstates | → Outperform | Get Alert |
| 11/15/2018 | ZIOP | Buy Now | ZIOPHARM Oncology | — | — | David Novak43% | → $5 | Upgrade | Market Perform → Outperform | Get Alert |
| 06/05/2018 | ZYME | Buy Now | Zymeworks | $11.71 | 130.57% | David Novak43% | $22 → $27 | Maintains | Outperform | Get Alert |
| 03/19/2018 | ZYME | Buy Now | Zymeworks | $11.71 | — | David Novak43% | — | Initiates | → Outperform | Get Alert |
| 06/02/2016 | ZIOP | Buy Now | ZIOPHARM Oncology | — | — | David Novak43% | — | Initiates | → Market Perform | Get Alert |
